Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab.

Smith, S.D.; Conrad, C.; Ramharter, M.; Gottlieb, A.B.; Patel, H.; Xu, W.; Riedl, E.; Schuster, C.

doi:10.1016/j.jaad.2020.02.045

Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab.

Details

Download: Integrated safety analysis- Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab.pdf (140.99 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0

Serval ID

serval:BIB_3FB5BC8CC849

Type

Article: article from journal or magazin.

Collection

Publications

Institution

UNIL/CHUV

Title

Integrated safety analysis: Frequency of urinary tract infections in patients with psoriasis treated with ixekizumab.

Journal

Journal of the American Academy of Dermatology

Author(s)

Smith S.D., Conrad C., Ramharter M., Gottlieb A.B., Patel H., Xu W., Riedl E., Schuster C.

ISSN

1097-6787 (Electronic)

ISSN-L

0190-9622

Publication state

Published

Issued date

07/2020

Peer-reviewed

Oui

Volume

83

Number

1

Pages

261-263

Language

english

Notes

Publication types: Letter
Publication Status: ppublish

Keywords

Adult, Aged, Antibodies, Monoclonal, Humanized/adverse effects, Clinical Trials as Topic, Dermatologic Agents/adverse effects, Female, Humans, Interleukin-17/antagonists & inhibitors, Interleukin-17/immunology, Male, Middle Aged, Pharmacovigilance, Psoriasis/diagnosis, Psoriasis/drug therapy, Psoriasis/immunology, Severity of Illness Index, Treatment Outcome, Urinary Tract Infections/chemically induced, Urinary Tract Infections/epidemiology, Urinary Tract Infections/immunology, Young Adult

URN

urn:nbn:ch:serval-BIB_3FB5BC8CC8496

OAI-PMH

oai:serval.unil.ch:BIB_3FB5BC8CC849

DOI

10.1016/j.jaad.2020.02.045

Pubmed

32092375

Web of science

000540826700097

Open Access

Yes